1-(6,7-Dimethoxyphthalazin-1-yl)piperidin-4-yl ethylcarbamate, 95.0%, 25mg

Soyasaponin I>98.0%(HPLC)10mg

(4,5-dimethoxy-2-nitrophenyl)acetonitrile, 98.0%, 25g

1-(3,5-Dichloropyridin-4-yl)ethan-1-one, 98+%, 5g

N-(4-(1-Aminoethyl)phenyl)cyclopropanecarboxamide, 98%, 500mg

2,3-DICHLORO-5-NITRO-1,4-NAPHTHOQUINONE, 97%, 5g

Chloro(tert-butyl)phenylphosphine, 98%, 5g

Methyl 3-(3-carbamoyl-4-(3-methoxyphenylamino)-8-methylquinolin-6-ylsulfonyl)benzoate, 98%, 50mg

2-Bromovaleric acid, 98.0%, 25g

bScope BS.1153-PLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

2-Amino-4-phenyl-6-(trifluoromethyl)pyrimidine, 98.0%, 1g

3,6-Dioxaoctanedioic acid, 95.0%, 100mg

5-Ethyl-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 500mg